Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Systemic Retinoic Acid on miRNA in Saliva and Serum
NCT07142070Not yet recruiting
- Sponsor
- Istanbul Medipol University
- Start
- Sep 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of isotretinoin in acne vulgaris, sponsored by Istanbul Medipol University. Primary endpoints: Pocket probing depth at 6 months, Clinical attachment level at 6 months and 1 more. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
isotretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07142070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07142070.